Literature DB >> 21124304

Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence.

John H Krystal1, Ismene L Petrakis, Diana Limoncelli, Susan Krasnicki Nappi, Louis Trevisan, Brian Pittman, Deepak C D'Souza, Raymond F Suckow.   

Abstract

Reduced responses to N-methyl-D-aspartate (NMDA) glutamate receptor antagonists in alcohol-dependent animals and humans provided evidence that chronic alcohol consumption increased NMDA receptor function. To further probe alterations in NMDA glutamate receptor function associated with human alcohol dependence, this study examined the interactive effects of agents acting at the glycine(B) coagonist site of the NMDA receptor. In doing so, it tested the hypothesis that raising brain glycine concentrations would accentuate the antagonist-like effects of the glycine(B) partial agonist, D-cycloserine (DCS). Twenty-two alcohol-dependent men and 22 healthy individuals completed 4 test days, during which glycine 0.3 g/kg or saline were administered intravenously and DCS 1000 mg or placebo were administered orally. The study was conducted under double-blind conditions with randomized test day assignment. In this study, DCS produced alcohol-like effects in healthy subjects that were deemed similar to a single standard alcohol drink. The alcohol-like effects of DCS were blunted in alcohol-dependent patients, providing additional evidence of increased NMDA receptor function in this group. Although glycine administration reduced DCS plasma levels, glycine accentuated DCS effects previously associated with the NMDA receptor antagonists, ketamine and ethanol. Thus, this study provided evidence that raising glycine levels accentuated the NMDA receptor antagonist-like effects of DCS and that alcohol-dependent patients showed tolerance to these DCS effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21124304      PMCID: PMC3055693          DOI: 10.1038/npp.2010.203

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  45 in total

1.  Determination of cycloserine in human plasma by high-performance liquid chromatography with fluorescence detection, using derivatization with p-benzoquinone.

Authors:  V David; M Ionescu; V Dumitrescu
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-09-15

2.  The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

Authors:  G Rammes; B Mahal; J Putzke; C Parsons; P Spielmanns; E Pestel; R Spanagel; W Zieglgänsberger; J Schadrack
Journal:  Neuropharmacology       Date:  2001-05       Impact factor: 5.250

3.  Dextromethorphan challenge in alcohol-dependent patients and controls.

Authors:  C G Schütz; M Soyka
Journal:  Arch Gen Psychiatry       Date:  2000-03

Review 4.  Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

Authors:  W Danysz; C G Parsons
Journal:  Pharmacol Rev       Date:  1998-12       Impact factor: 25.468

5.  Changes in NMDA receptor subunit gene expression in the rat brain following withdrawal from forced long-term ethanol intake.

Authors:  M B Darstein; G B Landwehrmeyer; T J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-02       Impact factor: 3.000

Review 6.  Regulation of NMDA receptors by ethanol.

Authors:  M Kumari; M K Ticku
Journal:  Prog Drug Res       Date:  2000

7.  Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine.

Authors:  A Sheinin; S Shavit; M Benveniste
Journal:  Neuropharmacology       Date:  2001-08       Impact factor: 5.250

8.  Effects of a novel uncompetitive NMDA receptor antagonist, MRZ 2/579 on ethanol self-administration and ethanol withdrawal seizures in the rat.

Authors:  P Bienkowski; P Krzascik; E Koros; W Kostowski; A Scinska; W Danysz
Journal:  Eur J Pharmacol       Date:  2001-02-09       Impact factor: 4.432

9.  Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.

Authors:  John H Krystal; Ismene L Petrakis; Diana Limoncelli; Elizabeth Webb; Ralitza Gueorgueva; D Cyril D'Souza; Nashaat N Boutros; Louis Trevisan; Dennis S Charney
Journal:  Neuropsychopharmacology       Date:  2003-11       Impact factor: 7.853

Review 10.  N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability.

Authors:  John H Krystal; Ismene L Petrakis; Graeme Mason; Louis Trevisan; D Cyril D'Souza
Journal:  Pharmacol Ther       Date:  2003-07       Impact factor: 12.310

View more
  15 in total

1.  D-Serine facilitates the effectiveness of extinction to reduce drug-primed reinstatement of cocaine-induced conditioned place preference.

Authors:  Sherri Hammond; Claire M Seymour; Ashley Burger; John J Wagner
Journal:  Neuropharmacology       Date:  2012-06-20       Impact factor: 5.250

Review 2.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

3.  Memantine, an NMDA receptor antagonist, differentially influences Go/No-Go performance and fMRI activity in individuals with and without a family history of alcoholism.

Authors:  S Jamadar; E E DeVito; R E Jiantonio; S A Meda; M C Stevens; M N Potenza; J H Krystal; G D Pearlson
Journal:  Psychopharmacology (Berl)       Date:  2012-02-04       Impact factor: 4.530

4.  Effects of memantine on event-related potential, oscillations, and complexity in individuals with and without family histories of alcoholism.

Authors:  Balaji Narayanan; Michael C Stevens; Rachel E Jiantonio; John H Krystal; Godfrey D Pearlson
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

Review 5.  Do specific NMDA receptor subunits act as gateways for addictive behaviors?

Authors:  F W Hopf
Journal:  Genes Brain Behav       Date:  2016-11-18       Impact factor: 3.449

6.  Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.

Authors:  Jennifer K Forsyth; Peter Bachman; Daniel H Mathalon; Brian J Roach; Elissa Ye; Robert F Asarnow
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

7.  Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain.

Authors:  Jennifer K Forsyth; Peter Bachman; Daniel H Mathalon; Brian J Roach; Robert F Asarnow
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

8.  D-Serine and D-Cycloserine Reduce Compulsive Alcohol Intake in Rats.

Authors:  Taban Seif; Jeffrey A Simms; Kelly Lei; Scott Wegner; Antonello Bonci; Robert O Messing; F Woodward Hopf
Journal:  Neuropsychopharmacology       Date:  2015-03-24       Impact factor: 7.853

9.  Astroglia in the Vulnerability and Maintenance of Alcohol Use Disorders.

Authors:  José Javier Miguel-Hidalgo
Journal:  Adv Neurobiol       Date:  2021

10.  Cocaine Experience Enhances Thalamo-Accumbens N-Methyl-D-Aspartate Receptor Function.

Authors:  Max E Joffe; Brad A Grueter
Journal:  Biol Psychiatry       Date:  2016-04-07       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.